Aevis Victoria's revenue for the
six
months ended in Dec. 2025 was CHF585 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF1,196 Mil.
Aevis Victoria's Revenue per Share for the
six
months ended in Dec. 2025 was CHF6.85.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF14.01.
During the past 12 months, the average Revenue per Share Growth Rate of Aevis Victoria was 18.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Aevis Victoria's highest 3-Year average Revenue per Share Growth Rate was 23.40% per year. The lowest was 0.90% per year. And the median was 5.20% per year.
Aevis Victoria (XSWX:AEVS) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Aevis Victoria Revenue Related Terms
Aevis Victoria Revenue Historical Data
* Premium members only.
The historical data trend for Aevis Victoria's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aevis Victoria's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aevis Victoria Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aevis Victoria's Revenue distribution charts can be found below:
* The bar in red indicates where Aevis Victoria's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1,196 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aevis Victoria (XSWX:AEVS) has a Revenue of CHF1,196 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Aevis Victoria and its competitors.
Is Aevis Victoria's Revenue too high?
Aevis Victoria's current Revenue is CHF1,196 Mil. Overall, Aevis Victoria has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aevis Victoria's Revenue compare to HCA and THC?
Aevis Victoria's Revenue of CHF1,196 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Aevis Victoria and its competitors. Aevis Victoria's current Revenue is CHF1,196 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aevis Victoria stock overvalued right now?
Based on GuruFocus' analysis, Aevis Victoria (XSWX:AEVS) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF16.94, compared to a current price of CHF12.25 — trading 27.7% below its estimated fair value. The current Revenue is CHF1,196 Mil. Aevis Victoria's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Aevis Victoria (XSWX:AEVS), the current Revenue is CHF1,196 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aevis Victoria (XSWX:AEVS) Overvalued in 2026?
Based on GuruFocus' analysis, Aevis Victoria stock appears to be undervalued.
The current stock price of CHF12.25 is trading 27.7% below its estimated GF Value™ of CHF16.94.
GuruFocus considers Aevis Victoria to be Modestly Undervalued.
Key valuation signals for XSWX:AEVS:
Revenue: CHF1,196 Mil
GF Value™: CHF16.94 vs. price of CHF12.25 (27.7% below fair value)
No single metric tells the full story. See the XSWX:AEVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aevis Victoria SA is a medical care company with five segments: Healthcare, Hospitality, Real Estate, Others, and Corporate. The Healthcare business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as urgent patient transport and hospital transfers. The Corporate segment operates other miscellaneous business activities. It generates the vast majority of its revenue in Healthcare segment.
54GF Score
Get the complete analysis for XSWX:AEVS
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AEVS has been successfully added to your 
